Internal Med Medical News about Cryptococcus neoformans

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mueller–Hinton methylene blue media as an alternative to RPMI 1640 for determining the susceptibility of Cryptococcus neoformans and Cryptococcus gattii to posaconazole with Etest
Mycoses, 10/28/09

Alvarado–Ramirez E et al. – Mueller–Hinton modified agar (MH–GMB) was compared with RPMI + 2% glucose–agar to determine the MICs of 80 isolates of Cryptococcus neoformans and C. gattii to posaconazole with Etest. MH–GMB minimised trailing and agreement between both media was 94%. Agreement of M27–A2 microbroth reference method was 98% with RPMI and 94% with MB–GMB.

Identification of Cryptococcus gattii using L-Canavanine Glycine Bromothymol Blue Medium and DNA Sequencing
Journal of Clinical Microbiology, 10/08/09 Relevance Score: 65%

New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance
Expert Review of Anti-infective Therapy, 10/16/09 Relevance Score: 40%